• Study on Acoramidis for Preventing Transthyretin Amyloidosis in Young People with a Genetic Risk

    Recruiting

    3 1
    Investigated diseases:
    Belgium Bulgaria Denmark France Germany Greece +6

  • Study on the Effects of Prednisolone Acetate and Placebo Eye Drops for Patients with Chronic Central Serous Chorioretinopathy

    Recruiting

    3 1 1
    Investigated diseases:
    The Netherlands

  • Long-term safety and effectiveness study of atacicept in patients with IgA nephropathy (IgAN)

    Recruiting

    2 1 1
    Belgium Czechia Germany Greece Poland Spain

  • Study on Protamine Sulfate for Reducing Bleeding and Ischemic Events in Adults with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

    Recruiting

    3 1 1
    Austria Germany

  • Study comparing Rilvegostomig plus chemotherapy versus Pembrolizumab plus chemotherapy for first-line treatment in patients with metastatic non-squamous lung cancer with PD-L1 expression

    Recruiting

    3 1 1 1
    Investigated diseases:
    Belgium France Germany Hungary Italy The Netherlands +2

  • Study on the Effect of Caffeine Citrate for Patients with Extubation Failure and Bronchopulmonary Dysplasia

    Recruiting

    3 1 1 1
    Investigated diseases:
    Hungary

  • Study on the Effects of Ketamine and Electroconvulsive Therapy for Patients with Treatment-Resistant Major Depressive Disorder

    Recruiting

    3 1 1
    Investigated diseases:
    Italy

  • Study of deucrictibant tablets for prevention of hereditary angioedema attacks in adults and adolescents

    Recruiting

    3 1 1
    Investigated diseases:
    Austria Bulgaria France Germany Hungary Ireland +5

  • Study on Betamethasone Sodium Phosphate to Prevent Asthma in Children with First-time Rhinovirus-induced Wheezing

    Recruiting

    3 1 1
    Investigated diseases:
    Finland Norway Sweden

  • Study on Adjusted Ciprofloxacin Dosing for Patients with Kidney Impairment and Bacterial Infections

    Recruiting

    3 1 1 1
    Investigated diseases:
    The Netherlands

powered by